FDA Inspection 1315416 — EdgeOne Medical Inc.
The FDA completed an inspection of EdgeOne Medical Inc. on March 25, 2026 in Wheeling, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 25, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Wheeling, IL (United States)